Androgen receptor CAG repeat length and association with prostate cancer risk: Results from the prostate cancer prevention trial

Journal of Urology

Volumn 184, Issue 6, 2010, Pages 2297-2302

  Price, Douglas K ^a   Chau, Cindy H ^a   Till, Cathee ^b   Goodman, Phyllis J ^b   Baum, Caitlin E ^a   Ockers, Sandy B ^a   English, Bevin C ^a   Minasian, Lori ^a   Parnes, Howard L ^a   Hsing, Ann W ^a   Reichardt, Juergen K V ^d   Hoque, Ashraful ^e   Tangen, Catherine M ^a   Kristal, Alan R ^c   Thompson, Ian M ^f   Figg, William D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF TEXAS   (United States)

^f University of Texas Health Science Center at San Antonio   (United States)

Author keywords

African continental ancestry group; European continental ancestry group; Prostate; Prostatic neoplasms; Receptors androgen

Indexed keywords

ANDROGEN RECEPTOR; FINASTERIDE; PLACEBO; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CAG REPEAT; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

AGED; CASE-CONTROL STUDIES; EXONS; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, ANDROGEN; RISK FACTORS;

EID: 78349310918     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.08.005     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
2. D.G. Bostwick, H.B. Burke, and D. Djakiew Human prostate cancer risk factors Cancer 101 2004 2371
3. J. Trapman, and K.B. Cleutjens Androgen-regulated gene expression in prostate cancer Semin Cancer Biol 8 1997 29
4. A. Edwards, H.A. Hammond, and L. Jin Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups Genomics 12 1992 241
5. S. Rajender, L. Singh, and K. Thangaraj Phenotypic heterogeneity of mutations in androgen receptor gene Asian J Androl 9 2007 147
6. E. Giovannucci Is the androgen receptor CAG repeat length significant for prostate cancer? Cancer Epidemiol Biomarkers Prev 11 2002 985
7. G.A. Coetzee, and R.K. Ross Re: prostate cancer and the androgen receptor J Natl Cancer Inst 86 1994 872
8. K.A. Nelson, and J.S. Witte Androgen receptor CAG repeats and prostate cancer Am J Epidemiol 155 2002 883
9. M.P. Zeegers, L.A. Kiemeney, and A.M. Nieder How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 13 2004 1765
10. E.M. Lange, A.V. Sarma, and A. Ray The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study J Hum Genet 53 2008 220
11. D. Mishra, K. Thangaraj, and A. Mandhani Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet 68 2005 55
12. R.D. Mittal, D. Mishra, and A.K. Mandhani Role of an androgen receptor gene polymorphism in development of hormone refractory prostate cancer in Indian population Asian Pac J Cancer Prev 8 2007 275
13. N. Nicolaiew, G. Cancel-Tassin, and A.R. Azzouzi Association between estrogen and androgen receptor genes and prostate cancer risk Eur J Endocrinol 160 2009 101
14. B. Silva Neto, W.J. Koff, and V. Biolchi Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population Cancer Invest 26 2008 74
15. I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215
16. P. Feigl, B. Blumenstein, and I. Thompson Design of the Prostate Cancer Prevention Trial (PCPT) Control Clin Trials 16 1995 150
17. M.L. Freedman, C.L. Pearce, and K.L. Penney Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study Am J Hum Genet 76 2005 82
18. E.A. Platz, M.F. Leitzmann, and N. Rifai Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era Cancer Epidemiol Biomarkers Prev 14 2005 1262
19. J. Simard, M. Dumont, and D. Labuda Prostate cancer susceptibility genes: lessons learned and challenges posed Endocr Relat Cancer 10 2003 225
20. P. Andersson, E. Varenhorst, and P. Soderkvist Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk Eur J Cancer 42 2006 2833
21. S.A. Ingles, R.K. Ross, and M.C. Yu Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor J Natl Cancer Inst 89 1997 166
22. A.W. Hsing, Y.T. Gao, and G. Wu Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China Cancer Res 60 2000 5111
23. E. Giovannucci, M.J. Stampfer, and K. Krithivas The CAG repeat within the androgen receptor gene and its relationship to prostate cancer Proc Natl Acad Sci U S A 94 1997 3320
24. S. Lindstrom, S.L. Zheng, and F. Wiklund Systematic replication study of reported genetic associations in prostate cancer: strong support for genetic variation in the androgen pathway Prostate 66 2006 1729
25. M.S. Forrest, S.M. Edwards, and R. Houlston Association between hormonal genetic polymorphisms and early-onset prostate cancer Prostate Cancer Prostatic Dis 8 2005 95
26. D.O. Hardy, H.I. Scher, and T. Bogenreider Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset J Clin Endocrinol Metab 81 1996 4400
27. R.A. Irvine, M.C. Yu, and R.K. Ross The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer Cancer Res 55 1995 1937
28. T. Gilligan, J. Manola, and O. Sartor Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population Clin Prostate Cancer 3 2004 98
29. M.L. Santos, A.S. Sarkis, and I.N. Nishimoto Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population Cancer Detect Prev 27 2003 321
30. O. Bratt, A. Borg, and U. Kristoffersson CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk Br J Cancer 81 1999 672